NEW YORK – About 12 to 15 percent of patients with breast cancer have multiple mutations in the PIK3CA gene, a new study has found, and about 95 percent of them are double mutations.
Double Mutations in PIK3CA Gene Increase Patient Sensitivity to Targeted Therapies, Study Finds
Premium
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.